학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 97건 | 목록 1~20
Academic Journal
Roider HG; Bayer AG, Pharmaceuticals, Berlin, Germany.; Hoff S; Bayer AG, Pharmaceuticals, Berlin, Germany.; Tseng SY; Bayer AG, Pharmaceuticals, San Francisco, USA.; Berndt S; Bayer AG, Pharmaceuticals, Berlin, Germany.; Trautwein M; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Filarsky K; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Current address: Roche Diagnostics GmbH, Penzberg, Germany.; Gritzan U; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Current address: Memorial Sloan Kettering Cancer Center, New York, USA.; Camps J; Bayer AG, Pharmaceuticals, Berlin, Germany.; Nadler WM; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Grudzinska-Goebel J; Bayer AG, Pharmaceuticals, Berlin, Germany.; Ellinger P; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Pesch T; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Soon CF; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Geyer M; Bayer AG, Pharmaceuticals, Berlin, Germany.; Gluske K; Bayer AG, Pharmaceuticals, Berlin, Germany.; Stelte-Ludwig B; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Current address: Vincerx Pharma, Monheim am Rhein, Germany.; Gorjánácz M; Bayer AG, Pharmaceuticals, Berlin, Germany. matyas.gorjanacz@bayer.com.
Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE
Academic Journal
Heller S; Nuvisan ICB GmbH, Berlin, Germany.; Glaeske S; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Gluske K; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Paul J; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Böhme A; Nuvisan ICB GmbH, Berlin, Germany.; Janzer A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Roider HG; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Montebaur A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Nicke B; Nuvisan ICB GmbH, Berlin, Germany.; Lesche R; Nuvisan ICB GmbH, Berlin, Germany.; von Ahsen O; Nuvisan ICB GmbH, Berlin, Germany.; Politz O; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Liu N; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Fosun Pharma, No. 1289 Yishan Road, Shanghai City, China.; Gorjánácz M; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany. matyas.gorjanacz@bayer.com.
Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE
Academic Journal
Ter Laak A; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Hillig RC; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Ferrara SJ; Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, 415 Main St., Cambridge, Massachusetts 02142, United States.; Korr D; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Barak N; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Lienau P; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Herbert S; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Fernández-Montalván AE; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Neuhaus R; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Gorjánácz M; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Puetter V; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Badock V; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Bone W; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Strathdee C; Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, 415 Main St., Cambridge, Massachusetts 02142, United States.; Siegel F; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Schatz C; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Nowak-Reppel K; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Doehr O; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Gradl S; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Hartung IV; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.; Meyerson M; Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, 415 Main St., Cambridge, Massachusetts 02142, United States.; Bouché L; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Kober C; Bayer AG, Pharmaceutical Division, Berlin, Germany.; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Roewe J; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.; Schmees N; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Roese L; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Roehn U; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Bader B; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Stoeckigt D; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Prinz F; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Gorjánácz M; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Roider HG; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Olesch C; Bayer AG, Pharmaceutical Division, Berlin, Germany.; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Leder G; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Irlbacher H; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Lesche R; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Lefranc J; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Oezcan-Wahlbrink M; Bayer AG, Pharmaceutical Division, Berlin, Germany.; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Batra AS; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.; Elmadany N; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.; Carretero R; Bayer AG, Pharmaceutical Division, Berlin, Germany.; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Sahm K; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.; Oezen I; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Cichon F; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Baumann D; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Sadik A; Brain Cancer Metabolism (B350), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Opitz CA; Brain Cancer Metabolism (B350), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Weinmann H; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Hartung IV; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Kreft B; Bayer AG, Pharmaceutical Division, Berlin, Germany.; Offringa R; DKFZ-Bayer Joint Immunotherapy Laboratory (D220), DKFZ-Bayer Joint Immunotherapy Laboratory, Heidelberg, Germany.; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.; Platten M; German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany m.platten@dkfz-heidelberg.de.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.; Gutcher I; Bayer AG, Pharmaceutical Division, Berlin, Germany.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Evans CM; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Phillips M; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Malone KL; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Tonelli M; National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, Madison, WI 53706, USA.; Cornilescu G; National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, Madison, WI 53706, USA.; Cornilescu C; National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, Madison, WI 53706, USA.; Holton SJ; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, 13353 Berlin, Germany.; Gorjánácz M; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, 13353 Berlin, Germany.; Wang L; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.; Carlson S; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Gay JC; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Nix JC; Molecular Biology Consortium, Advanced Light Source, Berkeley, CA 94720, USA.; Demeler B; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.; Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.; Markley JL; National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, Madison, WI 53706, USA.; Glass KC; Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: PubMed not MEDLINE
Academic Journal
Gorjánácz M; Bayer Pharma AG; Bayer Healthcare Pharmaceuticals; Global Drug Discovery; Therapeutic Research Group Oncology; Berlin, Germany.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101518322 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1949-1042 (Electronic) Linking ISSN: 19491034 NLM ISO Abbreviation: Nucleus Subsets: MEDLINE
Academic Journal
Gorjánácz M; European Molecular Biology Laboratory; Heidelberg, Germany. gorjanac@embl.de
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101518322 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1949-1042 (Electronic) Linking ISSN: 19491034 NLM ISO Abbreviation: Nucleus Subsets: MEDLINE
Academic Journal
Santarella-Mellwig R; European Molecular Biology Laboratory, Heidelberg, Germany.; Franke JJaedicke AGorjánácz MBauer UBudd AMattaj IWDevos DP
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE
Academic Journal
Gorjánácz M; European Molecular Biology Laboratory, Heidelberg, Germany.; Klerkx EPGaly VSantarella RLópez-Iglesias CAskjaer PMattaj IW
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0261-4189 (Print) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
Academic Journal
Rahm F; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Viklund J; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Trésaugues L; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Ellermann M; Bayer AG , Muellerstrasse 178 , 13353 Berlin , Germany.; Giese A; Bayer AG , Muellerstrasse 178 , 13353 Berlin , Germany.; Ericsson U; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Forsblom R; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Ginman T; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Günther J; Bayer AG , Muellerstrasse 178 , 13353 Berlin , Germany.; Hallberg K; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Lindström J; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Persson LB; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Silvander C; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Talagas A; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.; Díaz-Sáez L; Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7DQ , United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , United Kingdom.; Fedorov O; Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7DQ , United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , United Kingdom.; Huber KVM; Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7DQ , United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , United Kingdom.; Panagakou I; Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7DQ , United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , United Kingdom.; Siejka P; Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7DQ , United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , United Kingdom.; Gorjánácz M; Bayer AG , Muellerstrasse 178 , 13353 Berlin , Germany.; Bauser M; Bayer AG , Muellerstrasse 178 , 13353 Berlin , Germany.; Andersson M; Sprint Bioscience AB, Novum , 14157 Huddinge , Sweden.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Fernández-Montalván AE; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Berger M; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Kuropka B; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Koo SJ; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Badock V; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Weiske J; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Puetter V; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Holton SJ; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Stöckigt D; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Ter Laak A; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Centrella PA; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Clark MA; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Dumelin CE; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Sigel EA; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Soutter HH; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Troast DM; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Zhang Y; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Cuozzo JW; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Keefe AD; X-Chem Pharmaceuticals , Waltham, Massachusetts United States.; Roche D; Edelris , Lyon, France.; Rodeschini V; Edelris , Lyon, France.; Chaikuad A; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Díaz-Sáez L; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Bennett JM; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Fedorov O; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Huber KVM; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford , Oxford, United Kingdom.; Hübner J; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Weinmann H; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Hartung IV; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.; Gorjánácz M; Bayer AG , Pharmaceuticals, Drug Discovery, Berlin, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gorjánácz, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어